Brief: Pacira Biosciences Q3 Revenue USD 163.9 Million Vs. IBES Estimate USD 171.6 Million
02/11/2023 12:00
Nov 02 (Reuters) - Pacira Biosciences Q3 adjusted net income USD 36.6 million. * Q3 adjusted EBITDA USD 52.9 million * Q3 cash & investments USD 235.2 million * Q3 net income USD 10.9 million
Recent news on Pacira Biosciences
See all newsBrief: Pacira Biosciences Inc - Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote "For" All Of Pacira's Director Nominees
Brief: Pacira Biosciences Urges Stockholders To Vote "For" Election Of Pacira's Nominees On Blue Proxy Card
Brief: Doma Perpetual Urges Pacira Biosciences Shareholders To Judge Sale Price Adequacy
Brief: Doma Perpetual Capital Management Calls For Removal Of Pacira CEO And Strategic Sale
Brief: Pacira Biosciences Sends Letter To Stockholders Reiterating Superior Qualifications Of Its Board Nominees